Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of SelectQuote, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Investigation and Class Action - Shareholders who purchased SelectQuote securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to SelectQuote [2]. Group 2: Allegations and Stock Impact - SelectQuote was charged by the U.S. Department of Justice for allegedly paying hundreds of millions of dollars in illegal kickbacks to brokers from 2016 to 2021 in exchange for enrollments into Medicare Advantage plans [3]. - Following the announcement of these charges, SelectQuote's stock experienced a significant decline of 19.2% on May 1, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC is investigating GoHealth, Inc. (NASDAQ: GOCO) and certain of its officers and/or directors for potential securities fraud or other securities violations following a complaint recently filed by the Department of Justice alleging unlawful business practices involving a Medicare Advantage kickback scheme. If you are an investor in GoHealth, Inc. and purchased shares of GoHealth between 2016 and May 1, 2025, please consider contact ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 1, 2025, th ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving SelectQuote, Inc. following a lawsuit filed by the U.S. Department of Justice against the company and others in the health insurance sector [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of SelectQuote and is looking into whether the company and its officers engaged in illegal activities [1]. - The investigation is prompted by allegations that SelectQuote participated in a scheme involving illegal kickbacks related to Medicare Advantage plan enrollments [3]. Group 2: Legal Context - On May 1, 2025, the DOJ filed a False Claims Act complaint against SelectQuote and other insurers, claiming they paid hundreds of millions in illegal kickbacks from 2016 to 2021 [3]. - Following the announcement of the DOJ's lawsuit, SelectQuote's stock price dropped by $0.61, or 19.24%, closing at $2.56 per share [3]. Group 3: Firm Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [4].

3rd Quarter Fiscal 2025 Earnings Presentation May 12, 2025 | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continue," ...

Core Viewpoint - SelectQuote's stock price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage sector [1][3]. Company Investigation - Hagens Berman is investigating SelectQuote for potential misconduct regarding its sales practices and disclosures, particularly in its Senior business that offers Medicare Advantage plans [2][4]. - The investigation is focused on whether SelectQuote's claims of providing unbiased advice and comparison shopping for Medicare plans were misleading [3][4]. Allegations Against SelectQuote - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other brokers received substantial payments from insurers for enrollments into Medicare Advantage plans, which may have influenced their sales practices [7]. - It is claimed that SelectQuote directed beneficiaries to plans that provided the highest kickbacks, rather than those that were most suitable for the beneficiaries [7]. - The company allegedly incentivized employees to prioritize plans based on kickbacks and discriminated against Medicare Advantage beneficiaries with disabilities [7].

Core Viewpoint - GoHealth, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following a False Claims Act complaint filed by the U.S. Department of Justice against several health insurance companies, including GoHealth [1][2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against GoHealth on behalf of its stockholders [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, GoHealth and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments into Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ's lawsuit, GoHealth's stock price dropped by $1.09 per share, representing a decline of 10.35%, closing at $9.44 per share on May 1, 2025 [2].

Core Viewpoint - The Schall Law Firm is investigating SelectQuote, Inc. for potential violations of securities laws related to misleading statements and undisclosed information [1][2]. Investigation Details - The investigation centers on claims that SelectQuote may have issued false or misleading statements and failed to disclose critical information to investors [2]. - A DOJ False Claims Act was filed against SelectQuote on May 1, 2025, alleging that from 2016 to at least 2021, insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2]. - Following the news of the investigation, SelectQuote's shares dropped by 16% on the same day [2].

Core Viewpoint - SelectQuote's share price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage market [1][3]. Group 1: Lawsuit and Allegations - The U.S. Department of Justice filed a lawsuit against SelectQuote and other insurance brokers, claiming they violated the False Claims Act [1]. - The investigation focuses on SelectQuote's disclosures regarding its sales practices, particularly in its Senior business offering Medicare Advantage plans [2]. - Allegations include that SelectQuote directed Medicare beneficiaries to plans that provided the highest kickbacks to brokers, rather than acting in the best interest of the beneficiaries [5]. Group 2: Financial Impact - Following the announcement of the lawsuit, SelectQuote's shares fell by over 19% on May 1, 2025 [1][3]. - The lawsuit raises concerns about the potential inflation of SelectQuote's financial results due to alleged steering practices [4]. Group 3: Whistleblower Information - Whistleblowers with non-public information regarding SelectQuote are encouraged to assist in the investigation, with potential rewards of up to 30% of any successful recovery made by the SEC [4].

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ:GOCO). The investigation concerns whether GoHealth and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] On May 1, 2025, the U.S. Department of Justice filed a complaint against insurance broker organizations, including GoHealth ...